SEARCH

SEARCH BY CITATION

The aging population, the widespread use of prostate-specific antigen testing, and the introduction of new genetic tests will continue to increase the number of incident cases of localized prostate cancer. Because many of these men harbor low-risk disease, clinicians seriously should consider offering an active surveillance protocol.